Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Antivenom Serum Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Antivenom Serum Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Humans
      • 1.3.3 Animals
    • 1.4 Market Segment by Application
      • 1.4.1 Global Antivenom Serum Market Share by Application (2019-2025)
      • 1.4.2 Monovalent
      • 1.4.3 Polyvalent
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Antivenom Serum Market Size
      • 2.1.1 Global Antivenom Serum Revenue 2014-2025
      • 2.1.2 Global Antivenom Serum Sales 2014-2025
    • 2.2 Antivenom Serum Growth Rate by Regions
      • 2.2.1 Global Antivenom Serum Sales by Regions 2014-2019
      • 2.2.2 Global Antivenom Serum Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Antivenom Serum Sales by Manufacturers
      • 3.1.1 Antivenom Serum Sales by Manufacturers 2014-2019
      • 3.1.2 Antivenom Serum Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Antivenom Serum Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antivenom Serum Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Antivenom Serum Market Concentration Ratio (CR5 and HHI)
    • 3.3 Antivenom Serum Price by Manufacturers
    • 3.4 Key Manufacturers Antivenom Serum Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Antivenom Serum Market
    • 3.6 Key Manufacturers Antivenom Serum Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Humans Sales and Revenue (2014-2019)
      • 4.1.2 Animals Sales and Revenue (2014-2019)
    • 4.2 Global Antivenom Serum Sales Market Share by Type
    • 4.3 Global Antivenom Serum Revenue Market Share by Type
    • 4.4 Antivenom Serum Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Antivenom Serum Sales by Application

    6 United States

    • 6.1 United States Antivenom Serum Breakdown Data by Company
    • 6.2 United States Antivenom Serum Breakdown Data by Type
    • 6.3 United States Antivenom Serum Breakdown Data by Application

    7 European Union

    • 7.1 European Union Antivenom Serum Breakdown Data by Company
    • 7.2 European Union Antivenom Serum Breakdown Data by Type
    • 7.3 European Union Antivenom Serum Breakdown Data by Application

    8 China

    • 8.1 China Antivenom Serum Breakdown Data by Company
    • 8.2 China Antivenom Serum Breakdown Data by Type
    • 8.3 China Antivenom Serum Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Antivenom Serum Breakdown Data by Company
    • 9.2 Rest of World Antivenom Serum Breakdown Data by Type
    • 9.3 Rest of World Antivenom Serum Breakdown Data by Application
    • 9.4 Rest of World Antivenom Serum Breakdown Data by Countries
      • 9.4.1 Rest of World Antivenom Serum Sales by Countries
      • 9.4.2 Rest of World Antivenom Serum Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck
      • 10.1.1 Merck Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.1.4 Antivenom Serum Product Introduction
      • 10.1.5 Merck Recent Development
    • 10.2 Summerland Serums (AU)
      • 10.2.1 Summerland Serums (AU) Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.2.4 Antivenom Serum Product Introduction
      • 10.2.5 Summerland Serums (AU) Recent Development
    • 10.3 Haffkine Bio Pharmaceutical
      • 10.3.1 Haffkine Bio Pharmaceutical Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.3.4 Antivenom Serum Product Introduction
      • 10.3.5 Haffkine Bio Pharmaceutical Recent Development
    • 10.4 MicroPharm
      • 10.4.1 MicroPharm Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.4.4 Antivenom Serum Product Introduction
      • 10.4.5 MicroPharm Recent Development
    • 10.5 CSL (AU)
      • 10.5.1 CSL (AU) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.5.4 Antivenom Serum Product Introduction
      • 10.5.5 CSL (AU) Recent Development
    • 10.6 SAVP
      • 10.6.1 SAVP Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.6.4 Antivenom Serum Product Introduction
      • 10.6.5 SAVP Recent Development
    • 10.7 Flynn Pharma
      • 10.7.1 Flynn Pharma Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.7.4 Antivenom Serum Product Introduction
      • 10.7.5 Flynn Pharma Recent Development
    • 10.8 Serum
      • 10.8.1 Serum Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Antivenom Serum
      • 10.8.4 Antivenom Serum Product Introduction
      • 10.8.5 Serum Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Antivenom Serum Sales Channels
      • 11.2.2 Antivenom Serum Distributors
    • 11.3 Antivenom Serum Customers

    12 Market Forecast

    • 12.1 Global Antivenom Serum Sales and Revenue Forecast 2019-2025
    • 12.2 Global Antivenom Serum Sales Forecast by Type
    • 12.3 Global Antivenom Serum Sales Forecast by Application
    • 12.4 Antivenom Serum Forecast by Regions
      • 12.4.1 Global Antivenom Serum Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Antivenom Serum Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Antivenom Serum is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antivenom Serum.

      This report studies the global market size of Antivenom Serum, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Antivenom Serum sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Merck
      Summerland Serums (AU)
      Haffkine Bio Pharmaceutical
      MicroPharm
      CSL (AU)
      SAVP
      Flynn Pharma
      Serum

      Market Segment by Product Type
      Humans
      Animals

      Market Segment by Application
      Monovalent
      Polyvalent

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Antivenom Serum status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Antivenom Serum manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Antivenom Serum are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now